Pfizer Pharms Drug Patent Portfolio
Pfizer Pharms owns 2 orange book drugs protected by 6 US patents Given below is the list of Pfizer Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5859037 | Sulfonylurea-glitazone combinations for diabetes | 13 Nov, 2017 | Expired |
| US6011049 | Combinations for diabetes | 13 Nov, 2017 | Expired |
| US5684016 | Method of treating cardiac insufficiency | 04 May, 2015 | Expired |
| US5684016 | Method of treating cardiac insufficiency | 04 Nov, 2014 | Expired |
| US5602133 | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus | 15 Sep, 2013 | Expired |
| US6046202 | Use of thiazolidinedione derivatives in the treatment of insulin resistance | 15 Sep, 2013 | Expired |
Pfizer Pharms's Family Patents
Pfizer Pharms Drug List
Given below is the complete list of Pfizer Pharms's drugs and the patents protecting them.
1. Accupril
Accupril is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5684016
(Pediatric)
| Method of treating cardiac insufficiency |
04 May, 2015
(9 years ago)
| Expired |
| US5684016 | Method of treating cardiac insufficiency |
04 Nov, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Accupril's drug page
2. Rezulin
Rezulin is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5859037 | Sulfonylurea-glitazone combinations for diabetes |
13 Nov, 2017
(7 years ago)
| Expired |
| US6011049 | Combinations for diabetes |
13 Nov, 2017
(7 years ago)
| Expired |
| US5602133 | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
15 Sep, 2013
(11 years ago)
| Expired |
| US6046202 | Use of thiazolidinedione derivatives in the treatment of insulin resistance |
15 Sep, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Rezulin's drug page